Dahi‐Taleghani 2014.
Study characteristics | ||
Methods | Randomised, double‐blind, placebo control | |
Participants | N = 140, 100% men | |
Interventions | Postoperative ketamine 2 mg + morphine 2 mg via PCA | |
Outcomes | Pain intensity (VAS) reported at 1, 6 and 24 h postoperatively. Analgesic consumption reported at 24 h postoperatively. AEs | |
Surgery type | Elective orthopedic surgery for the lower limb | |
Group numbers after end of study (treatment/control) | 70/70 | |
Age of patient population (treatment/control) | 39.1 ± 7.2 38.3 ± 7.5 |
|
Notes | The study was supported financially in part by a research grant from the Anesthesiology Research Center, Shadid Beheshti University of Medical Sciences, Tehran, Iran | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Computer‐generated random number table |
Allocation concealment (selection bias) | Unclear risk | Allocation concealment method not described |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Only mentioned double‐blind |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Only mentioned double‐blind |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No withdrawals |
Selective reporting (reporting bias) | Low risk | All predefined outcomes reported |
Size | Unclear risk | 70 participants per treatment arm |